# 1. Financial Performance ## A. Key Figures * Revenue Growth: 8% YoY (full period) · ₹7,565.05 Cr Q3 (+118.81% YoY) * **EBITDA:** **₹1,928.15 Cr** operating EBITDA · **₹2,124 Cr** Q3 2026 (record) * **EBITDA Margin:** **>25%** (expanded significantly) ## B. Revenue Growth * **Robust Quarterly Momentum:** Exceptional 81% YoY revenue growth in Q3 driven by strong order execution and **surge in US-based demand**. * **Pricing & Mix Tailwinds:** Realizations rose sharply QoQ on favorable product mix and **25% margin expansion**, signaling improved value realization. ## C. EBITDA & Margins * **Record Profitability:** Q3 EBITDA surged to a record high, reflecting operating leverage and **structural margin stability** despite market volatility. * **Margin Protection Strategy:** Gross margin discipline maintained via **back-to-back cell tying** and internal efficiency levers across production and utilization. ## D. Cash Flow & Balance Sheet * **Strategic Capital Raise:** Raised **~₹1,000 Cr in equity** to fund a 20 GWh lithium-ion battery facility, advancing vertical integration goals. --- # 2. Order Book & Demand ## A. Key Figures * **Order Book:** **₹60,000 Cr** (record high) · **₹245 Cr** (transformers) * **Quarterly Order Inflow:** **₹20,500 Cr** (~80% solar) * Module Production: 3.5 GW (highest-ever quarterly) · +94% YoY * **Cell Production:** +35% QoQ * **Advance Payments:** **5–15%** of contract value (domestic) ## B. Total Order Inflow * **Robust Demand Visibility:** Record order book and strong quarterly inflow reflect sustained market confidence, with multi-year capacity largely pre-sold through FY28. * **Production Scaling:** Module output surged on strong demand, while cell production showed sequential improvement amid capacity ramp-up. * **Strategic Diversification:** Order book now reflects broader business mix beyond modules, with EPC and new segments contributing, though solar remains dominant. * **Project Infrastructure Buildout:** Secured over **5 GW of connectivity approvals** and **3,000+ acres of land**, enabling integrated project development and co-bidding opportunities. ## C. Booked vs. Pipeline * **Market Tailwinds from Stalled Projects:** ~42 GW of stalled Indian solar projects highlight structural bottlenecks, creating demand for Waaree’s full-stack project readiness solutions. * **Targeted Client Strategy:** Focus on institutional investors lacking project execution mandates, offering turnkey or co-bidding models with PPA success demonstrated via contracts with **global tech giants**. ## D. Advance Payment Terms * **Risk-Mitigated Order Conversion:** Domestic orders deemed firm only after advance payments; retail shipments require full payment, ensuring strong cash flow discipline. * **Commercial Prudence:** Variable advance terms (5–15%) allow flexibility while protecting against counterparty risk in evolving markets. --- # 3. Manufacturing & Utilization ## A. Key Figures * **Cell Utilization Rate:** **80–81%** current run rate (from ~56%) · **Daily utilization near 80%**, on track to **>90%** in 3–4 months * **Production Cost:** **¢7/W** current cell production cost in India, expected to decline with scale * **Capacity Expansion:** **10 GW** new cell capacity ramp-up to take **4–6 months per line**, improving to **~4 months** with experience ## B. Capacity Expansion * **Integrated Platform Visibility:** Manufacturing footprint showcased as a scalable, end-to-end solar and energy transition platform with domestic and international facilities highlighted. * **Strategic Location Advantage:** New facilities near **Vapi**, set to become a bullet train hub, will enhance logistics and workforce access via improved rail and highway connectivity. * **Expansion on Track:** Full operationalization of integrated modules, cells, and ingots & wafers plants expected by **FY27**, aligned with stated timelines. ## C. Cell Utilization Rate * **Strong Ramp-Up Momentum:** Cell utilization has materially improved from ~56% to a sustained **80–81%** run rate, with daily operations nearing **80%** and on path to exceed **90%** in coming months. * **Operational Hurdles Largely Cleared:** Initial technical challenges (effluent, breakages) are behind the company, enabling smoother scaling and higher yields. * **High-Efficiency Output:** Cell efficiency currently in the **24–25%** range, supporting strong watt-peak output and productivity. ## D. G12R Transition * **Imminent Technology Upgrade:** Major upgrades to adopt **G12R cell format** within 3 months, enabling higher watt-peak per cell and improved throughput. * **Utilization Catalyst:** G12R transition expected to push capacity utilization **above 85%**, with potential to reach **90%**, driven by larger cell size and enhanced productivity. --- # 4. Product & Segment Mix ## A. Key Figures * **Cell Production Split:** **35%** domestic · **65%** overseas (nearly fully captive) * **Module Sale Volume:** **300 MW** (distinct from production) * **Inverter Facility:** **1 GW** phase two expansion by **FY27** · **3 GW** total capacity (phase one commissioned) * **BESS Facility:** **20 GWh** planned capacity by **FY28** * **Transformer Orders:** **₹245 Cr** · Inverter orders in **similar range** * **Capex for Transformer Expansion:** **~₹192 Cr** to scale to **20,000 MVA** capacity ## B. Module & Cell Sales * **Vertical Integration Accelerates:** Transition to **Waaree 0**, a fully integrated multi-energy platform, with end-to-end control across the solar value chain enhancing project execution speed and platform strength. * **Captive Cell Strategy:** Majority of cell output sourced overseas but fully utilized in-house, supporting module production with limited external sales. * **Large-Scale Project Pipeline:** Execution underway across modules, cells, inverters, BESS, and green hydrogen, backed by a **100+ gigawatt project pipeline** signaling long-term demand visibility. ## C. Inverter & BESS Growth * **Localized Inverter Scale-Up:** Commissioning of phase one in Gujarat establishes domestic manufacturing footprint, with incremental **1 GW capacity by FY27** to meet rising demand and data security requirements. * **BESS Ambition with Early Traction:** 20 GWh facility targets full indigenization of key components; initial **pilot orders secured**, though business remains pre-commercial with no profitability metrics available. * **Pricing Divergence by Market:** U.S. BESS prices are **40–50% higher** than India’s $70–80/MWh landed cost, creating potential export incentives as scale is achieved. ## D. Transformer Orders * **Strategic Capacity Expansion:** Transformer business scaling to **20,000 MVA** to fill domestic supply gaps, with **₹245 Cr in orders** already secured—complemented by similar inverter order inflows. * **Portfolio Diversification:** Product expansion into distribution, inverter-duty, and EHV transformers strengthens integrated energy infrastructure offering. --- # 5. Geography & Export Mix ## A. Key Figures * **US Production:** **275 MW** (Q3) * **US Sales Volume:** **313 MW** (Q3) * **US Revenue:** **>₹2,000 Cr** (reported) * **US Realizations:** **>¢28/W**, up from **¢24–25/W** * **Non-DCR Realizations (India):** **₹18.5/Wp** * **DCR Realizations (India):** **₹23–24/Wp** ## B. US Revenue Breakdown * **Strategic Expansion:** Aggressive US footprint growth via **Meyer Burger asset acquisition** and Texas facility expansion, signaling long-term commitment to local manufacturing. * **Revenue Composition:** US top-line reflects a hybrid model—**mix of India exports and local US production**—with intercompany eliminations limiting transparency on exact split. * **Pricing Power:** Marked improvement in US realizations driven by **full tariff pass-through** and favorable market dynamics, now averaging **north of ¢28/W**. * **Incentive Utilization:** IRA benefits contribute meaningfully, though only **partial volume qualifies** for ¢7/W credit, resulting in **₹80 Cr recognized** vs. ~₹160 Cr potential. ## C. Domestic vs Overseas * **Export-Dominated Model:** Overseas markets represent **~96% of revenue**, underpinning the company’s global scale and limited domestic exposure. * **Infrastructure Buildout:** Secured **1 GW connectivity** and **~3,500 acres**, with **13,500 acres under acquisition**, enabling future project development despite sector-wide bottlenecks. * **Global Supply Chain:** Exports include modules using **non-India-sourced cells**, confirming multi-geography production footprint. ## D. Non-DCR vs DCR Sales * **DCR Premium:** Sharp realization gap persists—**DCR modules command ~5x premium** over non-DCR in India—highlighting policy-driven pricing divergence. * **Non-DCR Exposure:** Majority of domestic cell usage (~80–85%) remains non-DCR, though mix expected to evolve with new capacity. * **US vs India Non-DCR Spread:** Non-DCR realizations significantly higher in the **US (₹24–25/W)** versus India (₹14–15/W), reflecting structural market differences. --- # 6. Supply Chain & Input Costs ## A. Key Figures * **Silver Cost Impact:** **<9%** on module-level costs · **~25%** of cell-level costs * **Polysilicon Plant Timeline:** Production start expected in **current quarter** * **Cost Pressure Outlook:** **20%-25%** cost impact anticipated from silver prices and export rebate removal * **Cell Price Increase:** Risen from **¢4–¢5 to ~¢6/Wp** due to tapering Chinese export rebates ## B. Silver Cost Impact * **Contained Module Risk:** Silver’s impact on module margins remains limited to under **9%**, mitigated by operating leverage and pricing strategies despite **25% cost weight at cell level**. * **Margin Resilience Plan:** Management expects to offset a **20%-25% cost headwind** through scale, efficiency gains, and selective price increases, preserving gross margins. * **Contract Flexibility:** Customer agreements include both fixed pricing and commodity pass-through mechanisms, enabling risk-sharing amid volatility. ## C. Polysilicon Sourcing * **Strategic De-risking:** Fully traceable, non-Chinese polysilicon supply secured via investment in **United Solar Holdings (Oman)**, boosting U.S. and global market access. * **Near-Term Production Start:** Oman polysilicon plant has achieved financial closure and signed uptake agreements, with output expected this quarter. * **Favorable Global Shift:** Tapering of China’s export rebates lifts cell prices and validates true production costs, improving India’s competitive positioning. ## D. Equipment Procurement * **Geopolitical Risk Lifted:** Restrictions on critical equipment like crystal ingot pullers have eased, enabling multi-geography sourcing for India’s **10 GW ingot/wafer capacity target by FY27**. * **Open but Cautious Collaboration:** While domestic developers (ASM, Rana Semiconductor) are advancing, management prioritizes viable global supply chains over confirmed local partnerships. * **Procurement Discretion Maintained:** Specific suppliers and timelines remain undisclosed due to ongoing negotiations, though diverse global options are available. --- # 7. Risks & Regulatory Exposure ## A. Key Figures * **Provision (Exceptional Item):** **₹294 Cr** related to US investigation ## B. US Investigation & Compliance Posture * **Proactive Risk Management:** Company booked a significant exceptional provision despite no formal demand, underscoring a conservative and transparent stance amid an ongoing US investigation. * **Compliance Emphasis:** Leadership reaffirmed strict adherence to legal frameworks across jurisdictions and commitment to organizational transparency at this preliminary stage. ## C. Anti-Dumping & Trade Case Exposure * **Global Regulatory Strategy:** As a multinational player, the company employs a structured approach to navigate anti-dumping cases in Indonesia, India, and Laos, mitigating operational and financial risks. ## D. Tariff Mitigation & Supply Chain Strategy * **Origin-Based Tariff Navigation:** US tariff exposure is actively managed by aligning cell manufacturing with low-tariff jurisdictions, leveraging rules that tie origin to cell production location. * **Strategic Flexibility:** Supply chain footprint remains dynamic, with continuous adaptation to evolving global trade policies to minimize duty impacts. * **US Manufacturing Intent:** While currently no cell production in the US, the company maintains a strong strategic interest and is evaluating potential future investments. * **Quality Recognition:** Sustained Tier-1 status for 39 consecutive quarters reinforces global credibility and may support market access amid regulatory scrutiny. --- # 8. Guidance & Outlook ## A. Key Figures * **EBITDA Guidance (FY26):** **₹5,500–6,000 Cr** (visibility to surpass) * **Capex (Electrolyser Facility):** **₹676 Cr** (PLI award: ₹444 Cr) * **IRA Benefits (Quarterly):** **₹80 Cr** (at ¢7/Wp, 90% of eligible) ## B. FY26 EBITDA Visibility * **Outperformance Likely:** Clear line of sight to exceed FY26 EBITDA guidance, underpinned by strong execution and structural cost advantages. * **Cautious Forward Look:** No FY27 or medium-term EBITDA guidance provided, deemed premature despite confidence in margin resilience. ## C. Capex & PLI Projects * **Strategic Diversification:** Entry into green hydrogen with a 1 GW electrolyser facility, fully supported by PLI incentives and internal funding, targeted for FY27 commissioning. ## D. Demand Growth Trajectory * **Robust Sector Momentum:** Solar demand exhibiting exponential growth, led by retail and C&I segments, with 35 GW added in first 9 months of FY26—surpassing prior full-year levels. * **Demand-Supply Balance:** Domestic manufacturing capacity expansion not seen as overcapacity risk due to rapidly scaling demand and export-oriented production. * **Pricing & Returns:** Solar pricing remains stable; battery manufacturing could yield **2x–5x ROA**, though still in early development phase.